Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
High Growth Tech Stocks To Watch In February 2025

In This Article:

The Australian stock market has experienced a slight downturn, with the ASX200 declining by 0.17% to 8,308 points, influenced by a sell-off in consumer discretionary stocks and weaker performances from major banks following comments from the RBA governor on interest rate adjustments. In this environment of fluctuating market sentiment and sector-specific movements, identifying high growth tech stocks requires careful consideration of their innovation potential, competitive positioning, and ability to navigate economic shifts effectively.

Top 10 High Growth Tech Companies In Australia

Name

Revenue Growth

Earnings Growth

Growth Rating

Clinuvel Pharmaceuticals

21.39%

26.17%

★★★★★★

Adherium

86.80%

73.66%

★★★★★★

Pro Medicus

22.46%

23.62%

★★★★★★

Gratifii

40.96%

103.72%

★★★★★★

Telix Pharmaceuticals

20.38%

30.95%

★★★★★★

AVA Risk Group

25.54%

77.32%

★★★★★★

Mesoblast

49.04%

54.89%

★★★★★★

Pointerra

56.62%

126.45%

★★★★★★

Wrkr

44.16%

98.46%

★★★★★★

Opthea

51.59%

60.35%

★★★★★★

Click here to see the full list of 51 stocks from our ASX High Growth Tech and AI Stocks screener.

Let's dive into some prime choices out of from the screener.

Appen

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Appen Limited is an AI lifecycle company specializing in data sourcing, data annotation, and model evaluation solutions across Australia, the United States, and globally with a market cap of A$771.78 million.

Operations: Appen generates revenue primarily through its Global Services and New Markets segments, with Global Services contributing $155.04 million and New Markets $93.26 million. The company focuses on providing AI lifecycle solutions internationally, leveraging its expertise in data sourcing, annotation, and model evaluation to support diverse industries.

Despite a challenging landscape, Appen shows promise with an expected revenue growth of 5.9% annually, slightly outpacing the Australian market average of 5.7%. This growth is underpinned by strategic investments in R&D, crucial for maintaining competitiveness in the rapidly evolving tech sector. However, profitability remains a concern as APX is currently unprofitable with earnings forecasted to surge by 97.78% annually over the next three years. The company's commitment to innovation could be pivotal in transitioning from current losses to future profitability, reflecting its potential resilience and adaptability within high-growth tech sectors in Australia.

ASX:APX Revenue and Expenses Breakdown as at Feb 2025
ASX:APX Revenue and Expenses Breakdown as at Feb 2025

Codan

Simply Wall St Growth Rating: ★★★★☆☆